PH26637A - Hydroxylamine hearing amino acid derivatives - Google Patents

Hydroxylamine hearing amino acid derivatives Download PDF

Info

Publication number: PH26637A
Authority: PH; Philippines
Prior art keywords: group; alkyl; butyl; isobutylsuccinyl; protected
Prior art date: 1986-03-11

Application number

PH34996A

Other languages

English (en)

Inventor

Balraj Krishan Handa

William Henry Johnson

Peter James Machin

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-11

Filing date

1987-03-10

Publication date

1992-09-04

1986-03-11 Priority claimed from GB868605977A external-priority patent/GB8605977D0/en

1987-03-10 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1992-09-04 Publication of PH26637A publication Critical patent/PH26637A/en

Links

AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 title description 4
150000003862 amino acid derivatives Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 claims description 86
-1 p-hydroxymethyl Chemical group 0.000 claims description 77
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 40
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 39
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 32
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 22
238000000034 method Methods 0.000 claims description 15
150000003839 salts Chemical class 0.000 claims description 15
229910052799 carbon Inorganic materials 0.000 claims description 14
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 12
125000004432 carbon atom Chemical group C* 0.000 claims description 11
230000002378 acidificating effect Effects 0.000 claims description 10
229940024606 amino acid Drugs 0.000 claims description 10
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 10
230000007062 hydrolysis Effects 0.000 claims description 8
238000006460 hydrolysis reaction Methods 0.000 claims description 8
125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 claims description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 7
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
125000003277 amino group Chemical group 0.000 claims description 6
125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 6
229960003767 alanine Drugs 0.000 claims description 5
150000001408 amides Chemical class 0.000 claims description 5
125000003118 aryl group Chemical group 0.000 claims description 5
125000005101 aryl methoxy carbonyl group Chemical group 0.000 claims description 5
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
125000001495 ethyl group Chemical class [H]C([H])([H])C([H])([H])* 0.000 claims description 5
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
235000004279 alanine Nutrition 0.000 claims description 4
125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 4
239000012876 carrier material Substances 0.000 claims description 4
239000003814 drug Substances 0.000 claims description 4
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 4
125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims description 3
125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 claims description 3
239000004471 Glycine Substances 0.000 claims description 3
125000002252 acyl group Chemical group 0.000 claims description 3
229910052736 halogen Inorganic materials 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 3
201000008482 osteoarthritis Diseases 0.000 claims description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
125000001424 substituent group Chemical group 0.000 claims description 3
125000003396 thiol group Chemical group [H]S* 0.000 claims description 3
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 2
230000003301 hydrolyzing effect Effects 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 2
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 2
125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims 1
PMKXAKKWRBOEIC-QMMMGPOBSA-N ethyl 2-[[(2s)-2-amino-4-methylpentanoyl]amino]acetate Chemical compound CCOC(=O)CNC(=O)[C@@H](N)CC(C)C PMKXAKKWRBOEIC-QMMMGPOBSA-N 0.000 claims 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
OZVLILWRDWSCNL-UHFFFAOYSA-N phthalic acid terephthalic acid Chemical compound C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C1=CC=C(C(=O)O)C=C1)(=O)O OZVLILWRDWSCNL-UHFFFAOYSA-N 0.000 claims 1
230000002265 prevention Effects 0.000 claims 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 160
239000000243 solution Substances 0.000 description 132
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 110
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 94
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 71
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 71
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
239000000203 mixture Substances 0.000 description 58
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 54
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 48
229960001701 chloroform Drugs 0.000 description 47
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 45
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 42
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 39
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 38
238000001704 evaporation Methods 0.000 description 36
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 35
230000008020 evaporation Effects 0.000 description 35
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 31
239000002904 solvent Substances 0.000 description 30
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 29
239000007787 solid Substances 0.000 description 25
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 21
229910052943 magnesium sulfate Inorganic materials 0.000 description 21
235000019341 magnesium sulphate Nutrition 0.000 description 21
239000000706 filtrate Substances 0.000 description 20
238000010828 elution Methods 0.000 description 19
125000006239 protecting group Chemical group 0.000 description 19
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
239000006260 foam Substances 0.000 description 18
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
238000004587 chromatography analysis Methods 0.000 description 17
239000000741 silica gel Substances 0.000 description 17
229910002027 silica gel Inorganic materials 0.000 description 17
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
239000002253 acid Substances 0.000 description 16
239000000047 product Substances 0.000 description 16
235000017557 sodium bicarbonate Nutrition 0.000 description 16
229910000030 sodium bicarbonate Inorganic materials 0.000 description 16
JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 15
150000002443 hydroxylamines Chemical class 0.000 description 14
229960003136 leucine Drugs 0.000 description 14
239000007858 starting material Substances 0.000 description 14
238000001914 filtration Methods 0.000 description 13
239000004395 L-leucine Substances 0.000 description 12
238000009833 condensation Methods 0.000 description 12
230000005494 condensation Effects 0.000 description 12
229910052938 sodium sulfate Inorganic materials 0.000 description 11
235000011152 sodium sulphate Nutrition 0.000 description 11
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
125000004494 ethyl ester group Chemical group 0.000 description 10
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 10
XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 10
JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 9
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 9
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 9
239000003054 catalyst Substances 0.000 description 9
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
239000012043 crude product Substances 0.000 description 8
238000002844 melting Methods 0.000 description 8
230000008018 melting Effects 0.000 description 8
239000012074 organic phase Substances 0.000 description 8
238000003776 cleavage reaction Methods 0.000 description 7
150000002148 esters Chemical class 0.000 description 7
BMFVGAAISNGQNM-UHFFFAOYSA-N isopentylamine Chemical compound CC(C)CCN BMFVGAAISNGQNM-UHFFFAOYSA-N 0.000 description 7
238000010992 reflux Methods 0.000 description 7
230000007017 scission Effects 0.000 description 7
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
150000007513 acids Chemical class 0.000 description 6
238000007327 hydrogenolysis reaction Methods 0.000 description 6
239000000825 pharmaceutical preparation Substances 0.000 description 6
239000000758 substrate Substances 0.000 description 5
NPIMKSLXCPUXPD-SECBINFHSA-N (2r)-4-methyl-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]pentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)CC(=O)OC(C)(C)C NPIMKSLXCPUXPD-SECBINFHSA-N 0.000 description 4
108060005980 Collagenase Proteins 0.000 description 4
102000029816 Collagenase Human genes 0.000 description 4
VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
125000000217 alkyl group Chemical group 0.000 description 4
239000002775 capsule Substances 0.000 description 4
229960002424 collagenase Drugs 0.000 description 4
125000000524 functional group Chemical group 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
238000003756 stirring Methods 0.000 description 4
239000001117 sulphuric acid Substances 0.000 description 4
235000011149 sulphuric acid Nutrition 0.000 description 4
ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
ROBXZHNBBCHEIQ-BYPYZUCNSA-N ethyl (2s)-2-aminopropanoate Chemical compound CCOC(=O)[C@H](C)N ROBXZHNBBCHEIQ-BYPYZUCNSA-N 0.000 description 3
239000008101 lactose Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000000454 talc Substances 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
HHKUZUDKCCHXMN-GXTWGEPZSA-N (2r)-4-methyl-2-[(2s)-1-oxo-1-phenylmethoxypropan-2-yl]pentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)[C@H](C)C(=O)OCC1=CC=CC=C1 HHKUZUDKCCHXMN-GXTWGEPZSA-N 0.000 description 2
NZUBPFFSVXPWNB-GFCCVEGCSA-N (3r)-5-methyl-3-[(4-nitrophenyl)methoxycarbonyl]hexanoic acid Chemical compound CC(C)C[C@H](CC(O)=O)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NZUBPFFSVXPWNB-GFCCVEGCSA-N 0.000 description 2
GMIDOMGRHSRKOX-GFCCVEGCSA-N (4-nitrophenyl)methyl (2r)-2-hydroxy-4-methylpentanoate Chemical compound CC(C)C[C@@H](O)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 GMIDOMGRHSRKOX-GFCCVEGCSA-N 0.000 description 2
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 2
NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 2
YJNQRRCNDSQTQO-ZDUSSCGKSA-N 2-[[(2s)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 YJNQRRCNDSQTQO-ZDUSSCGKSA-N 0.000 description 2
MCRZWYDXIGCFKO-UHFFFAOYSA-N 2-butylpropanedioic acid Chemical compound CCCCC(C(O)=O)C(O)=O MCRZWYDXIGCFKO-UHFFFAOYSA-N 0.000 description 2
ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 2
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 2
PUOHYWANBYYBMW-UHFFFAOYSA-N 4-bromo-azacyclotridecan-2-one Chemical compound BrC1CCCCCCCCCNC(=O)C1 PUOHYWANBYYBMW-UHFFFAOYSA-N 0.000 description 2
LYMTUUPKTSFKAQ-UHFFFAOYSA-N 4-methyl-2-[(phenylmethoxyamino)methyl]pentanoic acid Chemical compound CC(C)CC(C(O)=O)CNOCC1=CC=CC=C1 LYMTUUPKTSFKAQ-UHFFFAOYSA-N 0.000 description 2
PHCUMMALIDGEDQ-OAHLLOKOSA-N 4-o-tert-butyl 1-o-[(4-nitrophenyl)methyl] (2r)-2-(2-methylpropyl)butanedioate Chemical compound CC(C)(C)OC(=O)C[C@@H](CC(C)C)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 PHCUMMALIDGEDQ-OAHLLOKOSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
HBCKGPQEHPLNAU-UHFFFAOYSA-N Cl.NC1CCCCCCCCCNC(=O)C1 Chemical compound Cl.NC1CCCCCCCCCNC(=O)C1 HBCKGPQEHPLNAU-UHFFFAOYSA-N 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
235000019759 Maize starch Nutrition 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
125000003545 alkoxy group Chemical group 0.000 description 2
BCDGQXUMWHRQCB-UHFFFAOYSA-N aminoacetone Chemical compound CC(=O)CN BCDGQXUMWHRQCB-UHFFFAOYSA-N 0.000 description 2
239000006286 aqueous extract Substances 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
150000001540 azides Chemical class 0.000 description 2
239000002585 base Substances 0.000 description 2
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
235000011089 carbon dioxide Nutrition 0.000 description 2
229960004424 carbon dioxide Drugs 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
239000002024 ethyl acetate extract Substances 0.000 description 2
MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000005984 hydrogenation reaction Methods 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical class [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 2
PBMIETCUUSQZCG-UHFFFAOYSA-N n'-cyclohexylmethanediimine Chemical compound N=C=NC1CCCCC1 PBMIETCUUSQZCG-UHFFFAOYSA-N 0.000 description 2
229910052754 neon Inorganic materials 0.000 description 2
GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
239000012044 organic layer Substances 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 2
238000007127 saponification reaction Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
229910021653 sulphate ion Inorganic materials 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
BWBHIIJKOYBHON-YFKPBYRVSA-N (2s)-2-(2-carboxyethylamino)pentanedioic acid Chemical compound OC(=O)CCN[C@H](C(O)=O)CCC(O)=O BWBHIIJKOYBHON-YFKPBYRVSA-N 0.000 description 1
BTLHODXEDLCLAD-VKHMYHEASA-N (2s)-2-(carboxymethylamino)butanedioic acid Chemical compound OC(=O)CN[C@H](C(O)=O)CC(O)=O BTLHODXEDLCLAD-VKHMYHEASA-N 0.000 description 1
XXSPTRGGCPZQFY-MERQFXBCSA-N (2s)-2-amino-4-methyl-n-[2-(3-methylbutylamino)-2-oxoethyl]pentanamide;hydrobromide Chemical compound Br.CC(C)CCNC(=O)CNC(=O)[C@@H](N)CC(C)C XXSPTRGGCPZQFY-MERQFXBCSA-N 0.000 description 1
KFJGNJHWBRBSNB-VIFPVBQESA-N (2s)-6-amino-2-(4-aminobutylamino)hexanoic acid Chemical compound NCCCCN[C@H](C(O)=O)CCCCN KFJGNJHWBRBSNB-VIFPVBQESA-N 0.000 description 1
LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
MWOJWUBBCZRMTB-ZDUSSCGKSA-N 2-[[(2s)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 MWOJWUBBCZRMTB-ZDUSSCGKSA-N 0.000 description 1
QPGLCMWTVFXYEU-UHFFFAOYSA-N 2-[[formyl(phenylmethoxy)amino]methyl]-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)CN(C=O)OCC1=CC=CC=C1 QPGLCMWTVFXYEU-UHFFFAOYSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
XQIHFGYUMFFCFG-UHFFFAOYSA-N 4-methyl-2-methylidenepentanoic acid Chemical compound CC(C)CC(=C)C(O)=O XQIHFGYUMFFCFG-UHFFFAOYSA-N 0.000 description 1
VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 1
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
241000258740 Abia Species 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
235000019766 L-Lysine Nutrition 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
HSQGMTRYSIHDAC-BQBZGAKWSA-N Leu-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(O)=O HSQGMTRYSIHDAC-BQBZGAKWSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
125000005011 alkyl ether group Chemical group 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000004658 aryl carbonyl amino group Chemical group 0.000 description 1
239000003637 basic solution Substances 0.000 description 1
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
239000000872 buffer Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
229940005991 chloric acid Drugs 0.000 description 1
FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
239000007859 condensation product Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000013058 crude material Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
238000010908 decantation Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical group CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
JCXLZWMDXJFOOI-WCCKRBBISA-N ethyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@H](C)N JCXLZWMDXJFOOI-WCCKRBBISA-N 0.000 description 1
BTKSUULMJNNXHG-UHFFFAOYSA-N ethyl 2-(methylamino)acetate Chemical compound CCOC(=O)CNC BTKSUULMJNNXHG-UHFFFAOYSA-N 0.000 description 1
UCPYKGBBOUITAZ-QRPNPIFTSA-N ethyl 2-[[(2s)-2-amino-4-methylpentanoyl]amino]acetate;hydrobromide Chemical compound Br.CCOC(=O)CNC(=O)[C@@H](N)CC(C)C UCPYKGBBOUITAZ-QRPNPIFTSA-N 0.000 description 1
SKBAOFNFKUKAMV-QRPNPIFTSA-N ethyl 2-[[(2s)-2-amino-4-methylpentanoyl]amino]acetate;hydrochloride Chemical compound Cl.CCOC(=O)CNC(=O)[C@@H](N)CC(C)C SKBAOFNFKUKAMV-QRPNPIFTSA-N 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
WVKIFIROCHIWAY-UHFFFAOYSA-N hydron;2-(methylamino)acetic acid;chloride Chemical compound Cl.CNCC(O)=O WVKIFIROCHIWAY-UHFFFAOYSA-N 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008274 jelly Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
DODCBMODXGJOKD-RGMNGODLSA-N methyl (2s)-2-amino-4-methylpentanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC(C)C DODCBMODXGJOKD-RGMNGODLSA-N 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical compound COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
125000005544 phthalimido group Chemical class 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
108010029690 procollagenase Proteins 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
150000003385 sodium Chemical class 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
229910000104 sodium hydride Inorganic materials 0.000 description 1
239000004289 sodium hydrogen sulphite Substances 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
238000010998 test method Methods 0.000 description 1
125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 1
238000001665 trituration Methods 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
239000004474 valine Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

PH34996A 1986-03-11 1987-03-10 Hydroxylamine hearing amino acid derivatives PH26637A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868605977A GB8605977D0 (en)	1986-03-11	1986-03-11	Hydroxylamine derivatives
GB868629712A GB8629712D0 (en)	1986-03-11	1986-12-12	Hydroxylamine derivatives

Publications (1)

Publication Number	Publication Date
PH26637A true PH26637A (en)	1992-09-04

Family

ID=26290467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH34996A PH26637A (en)	1986-03-11	1987-03-10	Hydroxylamine hearing amino acid derivatives

Country Status (11)

Country	Link
US (1)	US4996358A (ja)
EP (1)	EP0236872B1 (ja)
JP (1)	JPH0629228B2 (ja)
AU (1)	AU588437B2 (ja)
CA (1)	CA1314655C (ja)
DE (1)	DE3782751D1 (ja)
DK (1)	DK77487A (ja)
IE (1)	IE60128B1 (ja)
IL (1)	IL81790A0 (ja)
NZ (1)	NZ219494A (ja)
PH (1)	PH26637A (ja)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5686422A (en) *	1987-03-17	1997-11-11	Research Corporation Technologies, Inc.	Synthetic inhibitors of mammalian collagenase
WO1990005141A1 (en) *	1988-11-10	1990-05-17	Australian Commercial Research & Development Limited	Amino acid and peptide inhibitors of human leukocytic elastase and collagenase
GB8827305D0 (en) *	1988-11-23	1988-12-29	British Bio Technology	Compounds
GB8827308D0 (en) *	1988-11-23	1988-12-29	British Bio Technology	Compounds
DE3915755A1 (de) *	1989-05-13	1990-11-29	Bayer Ag	Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
GB8919251D0 (en) *	1989-08-24	1989-10-04	British Bio Technology	Compounds
EP0455818A4 (en) *	1989-11-24	1993-05-12	Banyu Pharmaceutical Co., Ltd.	Physiologically active substance be-16627
US5892112A (en) *	1990-11-21	1999-04-06	Glycomed Incorporated	Process for preparing synthetic matrix metalloprotease inhibitors
US5268384A (en) *	1990-11-21	1993-12-07	Galardy Richard E	Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
DE4102042A1 (de) *	1991-01-24	1992-07-30	Bayer Ag	Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
CA2058797A1 (en) *	1991-02-01	1992-08-02	Michael John Broadhurst	Amino acid derivatives
GB9102635D0 (en) *	1991-02-07	1991-03-27	British Bio Technology	Compounds
WO1992022523A2 (en) *	1991-06-14	1992-12-23	Research Corporation Technologies, Inc.	Peptide derivatives of collagenase inhibitor
EP0520573A1 (en) *	1991-06-27	1992-12-30	Glaxo Inc.	Cyclic imide derivatives
US5530161A (en) *	1991-07-08	1996-06-25	British Bio-Technology Limited	Hydroxamic acid based collagenase inhibitors
US5525629A (en) *	1992-04-07	1996-06-11	British Bio-Technology Limited	Inhibition of cytokine production
EP0639982A1 (en) *	1992-05-01	1995-03-01	British Biotech Pharmaceuticals Limited	Use of mmp inhibitors
GB9211706D0 (en) *	1992-06-03	1992-07-15	Celltech Ltd	Peptidyl derivatives
GB9211707D0 (en) *	1992-06-03	1992-07-15	Celltech Ltd	Peptidyl derivatives
AU666727B2 (en) *	1992-06-25	1996-02-22	F. Hoffmann-La Roche Ag	Hydroxamic acid derivatives
US5326760A (en) *	1992-06-29	1994-07-05	Glaxo, Inc.	Aminobutanoic acid compounds having metalloprotease inhibiting properties
GB9215665D0 (en) *	1992-07-23	1992-09-09	British Bio Technology	Compounds
GB9220845D0 (en) *	1992-10-03	1992-11-18	British Bio Technology	Vasoactive peptide inhibition
GB9223904D0 (en) *	1992-11-13	1993-01-06	British Bio Technology	Inhibition of cytokine production
US5506242A (en) *	1993-01-06	1996-04-09	Ciba-Geigy Corporation	Arylsufonamido-substituted hydroxamic acids
US5646167A (en) *	1993-01-06	1997-07-08	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamix acids
US5455258A (en) *	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
US5552419A (en) *	1993-01-06	1996-09-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
AU671724B2 (en) *	1993-03-16	1996-09-05	British Biotech Pharmaceuticals Limited	Hydroxamic acid derivatives as metalloproteinase inhibitors
US5594006A (en) *	1993-03-18	1997-01-14	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives as matrix metalloproteinases inhibitors
GB9320660D0 (en) *	1993-10-07	1993-11-24	British Bio Technology	Inhibition of cytokine production
US6037472A (en) *	1993-11-04	2000-03-14	Syntex (U.S.A.) Inc.	Matrix metalloprotease inhibitors
JP3297053B2 (ja) *	1994-01-20	2002-07-02	ブリテッシュバイオテックファーマシューティカルズリミテッド	金属タンパク質分解酵素阻害剤
GB9401034D0 (en) *	1994-01-20	1994-03-16	British Bio Technology	Metalloproteinase inhibitors
GB9401129D0 (en) *	1994-01-21	1994-03-16	British Bio Technology	Hydroxamic acid derivatives as metalloproteinase inhibitors
GB2299335B (en) *	1994-01-21	1997-12-17	British Biotech Pharm	Hydroxamic acid derivatives as metalloproteinase inhibitors
AU678884B2 (en) *	1994-01-22	1997-06-12	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
US5665753A (en) *	1994-03-03	1997-09-09	Smithkline Beecham Corporation	Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
GB9404046D0 (en) *	1994-03-03	1994-04-20	Smithkline Beecham Corp	Novel compounds
AU690703B2 (en) *	1994-06-22	1998-04-30	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
US5840698A (en) *	1994-10-27	1998-11-24	Affymax Technologies N.V.	Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) *	1994-10-27	1998-11-03	Affymax Technologies N.V.	Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
GB2308844B (en) *	1994-11-26	1998-09-02	British Biotech Pharm	Derivatives of Hydroxamic and Carboxylic Acids, and their use as Matrix Metalloproteinase
GB9423914D0 (en) *	1994-11-26	1995-01-11	British Biotech Pharm	Polyether derivatives as metalloproteinase inhibitors
US5639746A (en) *	1994-12-29	1997-06-17	The Procter & Gamble Company	Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5919940A (en) *	1995-01-20	1999-07-06	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
US5672598A (en) *	1995-03-21	1997-09-30	The Procter & Gamble Company	Lactam-containing hydroxamic acids
US6124333A (en) *	1995-06-22	2000-09-26	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
US5917090A (en) *	1995-06-30	1999-06-29	British Biotech Pharmaceuticals Ltd.	Matrix metalloproteinase inhibitors
GB9514867D0 (en) *	1995-07-20	1995-09-20	British Biotech Pharm	Metalloproteinase inhibitors
US6548084B2 (en) *	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
GB2318353B (en) *	1995-07-20	1999-10-06	British Biotech Pharm	Metalloproteinase inhibitors
NZ322553A (en)	1995-11-23	1998-12-23	British Biotech Pharm	Metalloproteinase inhibitors
US6777550B1 (en)	1996-04-12	2004-08-17	Bristol-Myers Squibb Company	N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors
WO1997038705A1 (en) *	1996-04-12	1997-10-23	Bristol-Myers Squibb Company	N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
WO1997042168A1 (en) *	1996-05-06	1997-11-13	Zeneca Limited	Thio derivatives of hydroxamic acids
US5932579A (en)	1996-06-18	1999-08-03	Affymax Technologies N.V.	Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
GB9613547D0 (en) *	1996-06-27	1996-08-28	Pharmacia Spa	Matrix metalloproteinase inhibitors
ATE226573T1 (de) *	1996-08-28	2002-11-15	Procter & Gamble	Heterozyklische metalloproteaseinhibitoren
HUP0000505A3 (en) *	1996-08-28	2001-12-28	Procter & Gamble	Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
HUP9903916A3 (en) *	1996-08-28	2001-06-28	Procter And Gamble Co Cincinna	Phosphinic acid amides and pharmaceutical compositions containing the same
TR199900429T2 (xx) *	1996-08-28	1999-05-21	The Procter & Gamble Company	Spirosiklik metaloproteaz inhibit�rleri.
CN1228771A (zh) *	1996-08-28	1999-09-15	普罗克特和甘保尔公司	1,3－二杂环金属蛋白酶抑制剂
US6462023B1 (en)	1996-09-10	2002-10-08	British Biotech Pharmaceuticals, Ltd.	Cytostatic agents
US6953788B1 (en)	1996-09-19	2005-10-11	Aventis Pharmaceuticals Inc.	3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
ES2178759T3 (es) *	1996-10-02	2003-01-01	Novartis Ag	Derivados de acido hidroxamico.
US5985911A (en) *	1997-01-07	1999-11-16	Abbott Laboratories	C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
US5952320A (en) *	1997-01-07	1999-09-14	Abbott Laboratories	Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
CN1265647A (zh)	1997-07-31	2000-09-06	普罗克特和甘保尔公司	无环金属蛋白酶抑制剂
PL194240B1 (pl) *	1998-02-07	2007-05-31	British Biotech Pharm	Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy
US6329418B1 (en)	1998-04-14	2001-12-11	The Procter & Gamble Company	Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6172064B1 (en)	1998-08-26	2001-01-09	Glaxo Wellcome Inc.	Formamides as therapeutic agents
US6329400B1 (en)	1998-08-26	2001-12-11	Glaxo Wellcome Inc.	Formamide compounds as therapeutic agents
EP1121118A4 (en) *	1998-08-26	2002-09-11	Glaxo Group Ltd	FORMAMIDE-BASED THERAPEUTIC AGENTS
GB9818605D0 (en)	1998-08-26	1998-10-21	Glaxo Group Ltd	Formamide compounds as therepeutic agents
US6288261B1 (en)	1998-12-18	2001-09-11	Abbott Laboratories	Inhibitors of matrix metalloproteinases
KR20010102486A (ko)	1999-03-03	2001-11-15	데이비드 엠 모이어	알케닐- 및 알키닐-함유 메탈로프로테아제 저해제
US6716878B1 (en) *	1999-04-09	2004-04-06	Vernalis (Oxford) Limited	Antimicrobial agents
JP2001055327A (ja) *	1999-06-11	2001-02-27	Fuji Chemical Industries Ltd	新規なヒドロキサム酸誘導体を含む医薬
ES2242411T3 (es) *	1999-08-10	2005-11-01	Vernalis (Oxford) Ltd	Agentes antibacterianos.
US6696456B1 (en) *	1999-10-14	2004-02-24	The Procter & Gamble Company	Beta disubstituted metalloprotease inhibitors
US6797820B2 (en)	1999-12-17	2004-09-28	Vicuron Pharmaceuticals Inc.	Succinate compounds, compositions and methods of use and preparation
US6509330B2 (en)	2000-02-17	2003-01-21	Bristol-Myers Squibb Company	Hydroxamic acid containing compounds useful as ACE inhibitors and/or NEP inhibotors
WO2001070682A2 (en) *	2000-03-21	2001-09-27	The Procter & Gamble Company	Carbocyclic side chain containing metalloprotease inhibitors
RU2245876C2 (ru) *	2000-03-21	2005-02-10	Дзе Проктер Энд Гэмбл Компани	Производные сульфонамидов и фармацевтическая композиция на их основе
CA2401728A1 (en) *	2000-03-21	2001-09-27	The Procter & Gamble Company	Difluorobutyric acid metalloprotease inhibitors
UY27192A1 (es) *	2001-03-01	2002-09-30	Smithkline Beecham Corp	Inhibidores de peptido-deformilasa
AR036053A1 (es)	2001-06-15	2004-08-04	Versicor Inc	Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
DK1406893T3 (da)	2001-06-15	2007-08-06	Vicuron Pharm Inc	Bicykliske pyrrolidinforbindelser
AU2003300379A1 (en) *	2002-12-27	2004-07-29	Angiotech Pharmaceuticals, Inc.	Compositions and methods of using collagen and MMPI

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA706911A (en) *		1965-03-30	Gaeumann Ernst	Process for the manufacture of long-chain trihydroxamic acids
GB999582A (en) *	1959-09-25	1965-07-28	Ciba Ltd	Trihydroxamic acids
DE1133360B (de) *	1961-02-18	1962-07-19	Basf Ag	Verfahren zur Herstellung von Harnstoffderivaten
DE1135890B (de) *	1961-03-16	1962-09-06	Basf Ag	Verfahren zur Herstellung von N-Hydroxyharnstoffen
US4028401A (en) *	1976-07-01	1977-06-07	Morton-Norwich Products, Inc.	(Substituted)ureidoacetohydroxamic acids
FR2480747A1 (fr) *	1980-04-17	1981-10-23	Roques Bernard	Derives d'acides amines et leur application therapeutique
NZ201998A (en) *	1981-09-25	1985-11-08	Wellcome Found	Amides and pharmaceutical compositions
FR2518088B1 (fr) *	1981-12-16	1987-11-27	Roques Bernard	Nouveaux derives d'aminoacides, et leur application therapeutique
GB8311286D0 (en) *	1983-04-26	1983-06-02	Searle & Co	Carboxyalkyl peptide derivatives
US4684482A (en) *	1984-01-26	1987-08-04	Oral-D (L.P.)	Orally effective ion chelators
US4671901A (en) *	1984-01-26	1987-06-09	Oral-D	Orally effective ion chelators
US4500518A (en) *	1984-04-19	1985-02-19	E. R. Squibb & Sons, Inc.	Amino thiol dipeptides
US4599198A (en) *	1985-08-02	1986-07-08	Pfizer Inc.	Intermediates in polypeptide synthesis
US4599361A (en) *	1985-09-10	1986-07-08	G. D. Searle & Co.	Hydroxamic acid based collagenase inhibitors
WO1987004440A1 (en) *	1986-01-23	1987-07-30	Pfizer Inc.	Heptanoyl-glu-asp-ala-amino acid immunostimulants

1987
- 1987-02-16 DK DK077487A patent/DK77487A/da not_active Application Discontinuation
- 1987-02-26 DE DE8787102771T patent/DE3782751D1/de not_active Expired - Fee Related
- 1987-02-26 EP EP87102771A patent/EP0236872B1/de not_active Expired - Lifetime
- 1987-03-03 CA CA000530988A patent/CA1314655C/en not_active Expired - Fee Related
- 1987-03-04 NZ NZ219494A patent/NZ219494A/xx unknown
- 1987-03-05 IL IL81790A patent/IL81790A0/xx not_active IP Right Cessation
- 1987-03-10 PH PH34996A patent/PH26637A/en unknown
- 1987-03-10 IE IE61087A patent/IE60128B1/en not_active IP Right Cessation
- 1987-03-11 AU AU69902/87A patent/AU588437B2/en not_active Ceased
- 1987-03-11 JP JP62056412A patent/JPH0629228B2/ja not_active Expired - Lifetime
1989
- 1989-04-11 US US07/336,264 patent/US4996358A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IE60128B1 (en)	1994-06-01
JPH0629228B2 (ja)	1994-04-20
NZ219494A (en)	1990-09-26
US4996358A (en)	1991-02-26
EP0236872A3 (en)	1989-09-13
DK77487A (da)	1987-09-12
AU588437B2 (en)	1989-09-14
AU6990287A (en)	1987-09-17
DK77487D0 (da)	1987-02-16
EP0236872B1 (de)	1992-11-25
EP0236872A2 (de)	1987-09-16
IE870610L (en)	1987-09-11
DE3782751D1 (de)	1993-01-07
JPS62230757A (ja)	1987-10-09
IL81790A0 (en)	1987-10-20
CA1314655C (en)	1993-03-16

Publication	Publication Date	Title
US4996358A (en)	1991-02-26	Hydroxylamine bearing amino acid derivatives as collagenase inhibitors
US5006651A (en)	1991-04-09	Phosphinic acid derivatives
EP0542525B1 (en)	1998-07-08	Antithrombotic agents
US4316889A (en)	1982-02-23	Novel peptidyl-arginine aldehyde derivatives and process for the preparation thereof
AU772024B2 (en)	2004-04-08	Inhibitors of urokinase and blood vessel formation
GB2085444A (en)	1982-04-28	Novel Anticoagulant agmatine derivatives and process for the preparation thereof
EP0038046B1 (en)	1984-02-29	Pharmaceutical amides, and preparation, formulations and use thereof
US5252566A (en)	1993-10-12	Antithrombotic agents
US5416093A (en)	1995-05-16	Antithrombotic agents
JPH02264795A (ja)	1990-10-29	グリシン誘導体
HU209413B (en)	1994-05-30	Method for producing 2-azabicyclo [3.1.0] hexane-3-carboxylic acid derivatives as well as their physiologically acceptable salts
HU204848B (en)	1992-02-28	Process for producing peptide derivatives with renin-inhibiting effect and pharmaceutical compositions comprising such compounds as active ingredient
BG60739B2 (bg)	1996-01-31	Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване
US4316892A (en)	1982-02-23	2,6-C-Dimethyltyrosine1 -D-amino acid2 -ε-amino caproic and γ aminobutyric acid5 derivatives of methionine enkephalin
US4346104A (en)	1982-08-24	Novel substituted phenylacetic acid amide compounds
US4250192A (en)	1981-02-10	Novel substituted phenylacetic acid amide compounds
US4420490A (en)	1983-12-13	Substituted phenylacetic acid amide compounds
HU185229B (en)	1984-12-28	Process for preparing pharmaceutically active peptides and acetates thereof
US4421744A (en)	1983-12-20	Aminoacyl derivatives
JP2003509409A (ja)	2003-03-11	アザシクロアルカノンセリンプロテアーゼ阻害剤
HU203770B (en)	1991-09-30	Process for producing histidine derivatives and pharmaceutical compositions containing them as active components
AU721261B2 (en)	2000-06-29	Peptide inhibitors of hematopoietic cell proliferation
EP0004394B1 (en)	1981-04-15	Psychopharmacological peptides, process for their preparation and their pharmaceutical formulations
US6228841B1 (en)	2001-05-08	Peptide derivatives
US6649593B1 (en)	2003-11-18	Modulators of SREBP processing